Rabeprazole and Meropenem drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Rabeprazole (rabeprazole sodium) and Meropenem (meropenem). Common drug interactions include hepatitis c among females and pyrexia among males.
The phase IV clinical study analyzes what interactions people have when they take Rabeprazole and Meropenem. It is created by eHealthMe based on reports of 279 people who take the same drugs from the FDA, and is updated regularly.
What is Rabeprazole?
Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.
What is Meropenem?
Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
279 people who take Rabeprazole and Meropenem together, and have interactions are studied.
What are the common drug interactions of Rabeprazole and Meropenem, by gender? *
What are the common drug interactions of Rabeprazole and Meropenem, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Rabeprazole and Meropenem?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Rabeprazole (31,689 reports)
- Meropenem (33,295 reports)
Browse all drug interactions of Rabeprazole and Meropenem:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rabeprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Meropenem:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rabeprazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Meropenem and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on rabeprazole sodium and meropenem (the active ingredients of Rabeprazole and Meropenem, respectively), and Rabeprazole and Meropenem (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hypoglycemia and drugs of ingredients of tretinoin - now
- Drug interactions of Acth and Losartan - a second ago
- Could Humira cause Rashes? - a second ago
- Could Sertraline cause Hypothyroidism? - 3 seconds ago
- Lexapro and Yaz drug interactions for girls aged 10-19 - 3 seconds ago
- Hospitalisation and drugs of ingredients of benztropine mesylate - 5 seconds ago
- Drug interactions of Tekturna and Aspirin - 6 seconds ago
- Methocarbamol and Clopidogrel drug interactions for men aged 50-59 - 8 seconds ago
- Drug interactions of Singulair and Grape - 10 seconds ago
- Could Avastin cause Drug-Induced Liver Injury? - 13 seconds ago